We’re here in STAT’s Brooklyn outpost today, where everyone’s gazing across the East River to see whether Pfizer’s former ...

The top contenders to lead the Food and Drug Administration have been sent to the White House for a final review and decision ...

BOSTON — The state of Massachusetts’ largest-ever nurses strike, and the first at Brigham and Women’s Hospital, is off to a boisterous start. Thousands of Brigham nurses and supporters poured onto ...

It’s time to bring production of essential medications back to the U.S. — or at least closer to home.  The meeting, described ...

Bob covers the money in health care, focusing on health insurance and hospitals. His stories delve into Medicare Advantage, ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

Sarah covers how industries like food and tobacco affect Americans’ bodies and minds. Her interests include ultra-processed foods; smoke-free tobacco; and wellness trends like perimenopause products ...

Liz covers cardiovascular and metabolic disease, asking why we’re not doing better or even losing ground against the world’s leading killer. Send tips on Signal at LizC.22. Could a lifesaving lung ...

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. Prime Medicine said Wednesday that it had ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Ebola has once again cropped up in Uganda and the Democratic Republic of the Congo. We’ve contained the disease before. But ...

Read the 5 key takeaways from STAT's series "Out of Pocket, Out of Reach," an examination of workplace health insurance.